eli lilly glp-1 agonist The challenge of developing oral alternatives to Ozempic, Wegovy and Mounjaro US approves new oral weight-loss

Main areas of active research interest: tendon and ligament repair, inflammatory bowel disease, traumatic-brain-injury recovery, and stress-related GI ulceration

For example, someone managing a chronic condition might need a higher dose compared to someone using glutathione for general maintenance

Gastrointestinal Outcomes in Post-Cholecystectomy Patients Retrospective data indicates 1015% of post-cholecystectomy patients experience increased stool frequency or bile acid diarrhea when starting GLP-1 therapy

IBS tissue samples show a lower GR activity than normal colon tissue

One substance that has in recent years appeared in news reports is acetyl-L-carnitine